Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Surgical Oncology Clinics of North America|March 11, 2020
Workup of Gastroenteropancreatic Neuroendocrine TumorsJoseph S DillonCurrent Drug Targets. Inflammation and Allergy|August 17, 2005
Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disordersJoseph S DillonThe Journal of Biological Chemistry|April 6, 2002
Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3)Dongmin Liu, Joseph S DillonEndocrinology and Metabolism Clinics of North America|August 2, 2017
Biochemical Testing in Neuroendocrine TumorsVidya Aluri, Joseph S DillonFuture Oncology (London, England)|January 20, 2018
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrheaJoseph S Dillon, Chandrikha ChandrasekharanSteroids|June 9, 2004
Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptorDongmin Liu, Joseph S DillonObesity Research & Clinical Practice|December 17, 2013
BMI misclassification, leptin, C-reactive protein, and interleukin-6 in young women with differing levels of lean and fat massM Kathleen Clark, Joseph S DillonSeminars in Reproductive Medicine|January 7, 2005
Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate?Richard L Widstrom, Joseph S DillonCurrent Problems in Cancer|August 30, 2024
Management of functional neuroendocrine tumorsAmr Wahba, Zi Tan, Joseph S DillonFuture Oncology (London, England)|January 28, 2021
High-specific-activity <sup>131</sup>iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paragangliomaJoseph S Dillon, David Bushnell, Douglas E LauxPageof 6